BackLiminatus Pharma Warrants Overview

Liminatus Pharma Warrants Total Current Liabilities

Track Liminatus Pharma Warrants's total current liabilities ($1.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.86M
611.32% YoYΔ $1.60M vs prior year quarter

Peer average

Loading

Liminatus Pharma Warrants Total Current Liabilities History

Loading

Liminatus Pharma Warrants vs. peers: Total Current Liabilities Comparison

Loading

Liminatus Pharma Warrants Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Liminatus Pharma Warrants (LIMNW) FAQ

Liminatus Pharma Warrants posts a total current liabilities of $1.9M as of March 2022. That compares with $260K in the prior-year period — up 611.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Liminatus Pharma Warrants's total current liabilities was $260K. The latest reading is $1.9M — a 611.3% year-over-year increase (period ending March 2022). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Liminatus Pharma Warrants's financial statement story. At $1.9M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LIMNW's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Liminatus Pharma Warrants's other metric pages and overview cover the third.